AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...

Investors were reassured after the drugmaker said a potential fine in China would have only a minor business impact.The ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

LONDON (Reuters) -- AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's former senior executive Leon Wang and has provided ...

AstraZeneca appointed a new president for its China operations following the arrest of former executive Leon Wang along with ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

Drugmaker AstraZeneca has warned it could face a fine in China over possible unpaid import taxes, as it revealed strong sales ...

In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...

AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...

AstraZeneca said the taxes related to two cancer drugs, Imfinzi and Imjudo, and that it was continuing to co-operate with ...

AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities ...